$NTRA news
The latest NTRA stock news: headlines, filings, AI summaries and sentiment for $NTRA, updated around the clock.
- Natera Reports Q3 2026 Revenue Growth of 34% and Raises Full-Year Guidance
- Natera Shares Decline Following Third Quarter Earnings Miss and CEO Departure
- Natera, Inc. - 10-Q Filing
- Natera Reports Q3 Revenue Beat Amid GAAP EPS Miss
- Natera, Inc. - 8-K Filing
- Natera CEO Steven Chapman Sells Shares Under Pre-Planned Trading Plan
- Natera CEO Steven Chapman Sells Shares Worth $545,000
- Stanley Druckenmiller Holds Significant Stake in Natera Amid Strong Growth
- Stanley Druckenmiller's Duquesne Family Office Increases Healthcare Stock Holdings
- Stanley Druckenmiller's Q2 Portfolio Includes Amazon, Alphabet, but His Largest Holding Is Genetic Testing Company Natera
- Stanley Druckenmiller's Duquesne Family Office Portfolio Update for Q1 2026
- U.S. Supreme Court Declines to Hear CareDx's Appeal Against Natera
- Natera (NASDAQ:NTRA) Collaborates with CytoDyn on ctDNA-Guided mCRC Clinical Trials
- Natera's Expansion in Cancer Recurrence Testing Attracts Investment from Wood's Ark
- Natera, Inc. - 10-Q Filing
- Natera Reports Q1 2026 Financial Results with Strong Revenue Growth
- Natera, Inc. - 8-K Filing
- William Blair Initiates Coverage on Natera with Outperform Rating